OxLDL-targeted iron oxide nanoparticles for in vivo MRI detection of perivascular carotid collar induced atherosclerotic lesions in ApoE-deficient mice

Journal of Lipid Research

Volumn 53, Issue 5, 2012, Pages 829-838

  Wen, Song ^a   Liu, Dong Fang ^a   Liu, Zhen ^b   Harris, Steven ^c   Yao, Yu Yu ^a   Ding, Qi ^a   Nie, Fang ^a   Lu, Tong ^a   Chen, Hua Jun ^a   An, Yan Li ^a   Zang, Feng Chao ^a   Teng, Gao Jun ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c Emory University   (United States)

Author keywords

Atherosclerosis; Low density lipoprotein; Magnetic resonance imaging; Molecular imaging

Indexed keywords

APOLIPOPROTEIN E; IODINE 125; MACROGOL; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYCLONAL ANTIBODY; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; CELLULAR DISTRIBUTION; COMPETITIVE INHIBITION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; IMAGE ANALYSIS; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

ANIMALS; APOLIPOPROTEINS E; CAROTID ARTERIES; CONSTRICTION; CONTRAST MEDIA; FERRIC COMPOUNDS; LIPOPROTEINS, LDL; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES; PLAQUE, ATHEROSCLEROTIC; POLYETHYLENE GLYCOLS;

EID: 84860307536     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M018895     Document Type: Article

References (43)

1. Roger, V. L., A. S. Go, D. M. Lloyd-Jones, R. J. Adams, J. D. Berry, T. M. Brown, M. R. Carnethon, S. Dai, G. de Simone, E. S. Ford, et al. 2011. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 123: e18-e209.
2. Fuster, V., P. R. Moreno, Z. A. Fayad, R. Corti, and J. J. Badimon. 2005. Atherothrombosis and high-risk plaque: part I: evolving concepts. J. Am. Coll. Cardiol. 46: 937-954. (Pubitemid 41316498)
3. Fayad, Z. A. 2001. The assessment of the vulnerable atherosclerotic plaque using MR imaging: a brief review. Int. J. Cardiovasc. Imaging. 17: 165-177. (Pubitemid 33121043)
4. Matsuura, E., G. R. Hughes, and M. A. Khamashta. 2008. Oxidation of LDL and its clinical implication. Autoimmun. Rev. 7: 558-566.
5. Namgaladze, D., A. Kollas, and B. Brune. 2008. Oxidized LDL attenuates apoptosis in monocytic cells by activating ERK signaling. J. Lipid Res. 49: 58-65.
6. Nishi, K., H. Itabe, M. Uno, K. T. Kitazato, H. Horiguchi, K. Shinno, and S. Nagahiro. 2002. Oxidized LDL in carotid plaques and plasma associates with plaque instability. Arterioscler. Thromb. Vasc. Biol. 22: 1649-1654.
7. Ishigaki, Y., H. Katagiri, J. Gao, T. Yamada, J. Imai, K. Uno, Y. Hasegawa, K. Kaneko, T. Ogihara, H. Ishihara, et al. 2008. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation. 118: 75-83.
8. Briley-Saebo, K. C., Y. S. Cho, P. X. Shaw, S. K. Ryu, V. Mani, S. Dickson, E. Izadmehr, S. Green, Z. A. Fayad, and S. Tsimikas. 2011. Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation- specific epitopes. J. Am. Coll. Cardiol. 57: 337-347.
9. Briley-Saebo, K. C., T. H. Nguyen, A. M. Saeboe, Y. S. Cho, S. K. Ryu, E. Volkava, S. Dickson, G. Leibundgut, P. Weisner, S. Green, et al. 2012. In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes. J. Am. Coll. Cardiol. 59: 616-626.
10. Briley-Saebo, K. C., P. X. Shaw, W. J. Mulder, S. H. Choi, E. Vucic, J. G. Aguinaldo, J. L. Witztum, V. Fuster, S. Tsimikas, and Z. A. Fayad. 2008. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation. 117: 3206-3215.
11. Briley-Saebo, K. C., Y. S. Cho, and S. Tsimikas. 2011. Imaging of oxidation-specific epitopes in atherosclerosis and macrophage-rich vulnerable plaques. Curr Cardiovasc Imaging Rep. 4: 4-16.
12. Wu, T., W. C. Willett, N. Rifai, I. Shai, J. E. Manson, and E. B. Rimm. 2006. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among US men and women? J. Am. Coll. Cardiol. 48: 973-979. (Pubitemid 44292442)
13. Ishigaki, Y., Y. Oka, and H. Katagiri. 2009. Circulating oxidized LDL: a biomarker and a pathogenic factor. Curr. Opin. Lipidol. 20: 363-369.
14. Jackson, C. L., M. R. Bennett, E. A. Biessen, J. L. Johnson, and R. Krams. 2007. Assessment of unstable atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 27: 714-720. (Pubitemid 46606696)
15. Majesky, M. W. 2002. Mouse model for atherosclerotic plaque rupture. Circulation. 105: 2010-2011. (Pubitemid 34465260)
16. von der Thusen, J. H., T. J. van Berkel, and E. A. Biessen. 2001. Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation. 103: 1164-1170.
17. Chyu, K. Y., S. M. Babbidge, X. Zhao, R. Dandillaya, A. G. Rietveld, J. Yano, P. Dimayuga, B. Cercek, and P. K. Shah. 2004. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation. 109: 2448-2453. (Pubitemid 38679566)
18. Yuan, C., L. M. Mitsumori, M. S. Ferguson, N. L. Polissar, D. Echelard, G. Ortiz, R. Small, J. W. Davies, W. S. Kerwin, and T. S. Hatsukami. 2001. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation. 104: 2051-2056. (Pubitemid 33027045)
19. Saam, T., T. S. Hatsukami, N. Takaya, B. Chu, H. Underhill, W. S. Kerwin, J. Cai, M. S. Ferguson, and C. Yuan. 2007. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology. 244: 64-77. (Pubitemid 46981959)
20. Wang, J., N. Balu, G. Canton, and C. Yuan. 2010. Imaging biomarkers of cardiovascular disease. J. Magn. Reson. Imaging. 32: 502-515.
21. Tang, T. Y., S. P. Howarth, S. R. Miller, M. J. Graves, A. J. Patterson, J. M. U-King-Im, Z. Y. Li, S. R. Walsh, A. P. Brown, P. J. Kirkpatrick, E. A. Warburton, P. D. Hayes, K. Varty, J. R. Boyle, M. E. Gaunt, A. Zalewski, and J. H. Gillard. 2009. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J. Am. Coll. Cardiol. 53: 2039-2050.
22. Persigehl, T., R. Bieker, L. Matuszewski, A. Wall, T. Kessler, H. Kooijman, N. Meier, W. Ebert, W. E. Berdel, W. Heindel, et al. 2007. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice. Radiology. 244: 449-456. (Pubitemid 47080876)
23. Winter, P. M., A. M. Morawski, S. D. Caruthers, R. W. Fuhrhop, H. Zhang, T. A. Williams, J. S. Allen, E. K. Lacy, J. D. Robertson, G. M. Lanza, et al. 2003. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation. 108: 2270-2274. (Pubitemid 37363046)
24. Trivedi, R. A., J. M. U-King-Im, M. J. Graves, J. J. Cross, J. Horsley, M. J. Goddard, J. N. Skepper, G. Quartey, E. Warburton, I. Joubert, L. Wang, P. J. Kirkpatrick, J. Brown, and J. H. Gillard. 2004. In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke. 35: 1631-1635.
25. Zhen, L., L. Wei, M. Y. Gao, and H. Lei. 2005. One-pot reaction to synthesize biocompatible magnetite nanoparticles. Adv. Mater. (Deerfield Beach Fla.). 17: 1001-1005.
26. Hu, F. Q., W. Li, Z. Zhou, Y. L. Ran, L. Zhen, and M. Y. Gao. 2006. Preparation of biocompatible magnetite nanocrystals for in vivo magnetic resonance detection of cancer. Adv. Mater. (Deerfield Beach Fla.). 18: 2553-2556.
27. Liu, S. J., B. Jia, R. R. Qiao, Z. Yang, Z. L. Yu, Z. F. Liu, K. Liu, J. Y. Shi, H. Ouyang, F. Wang, et al. 2009. A novel type of dual-modality molecular probe for mr and nuclear imaging of tumor: preparation, characterization and in vivo application. Mol. Pharm. 6: 1074-1082.
28. Gao, Q., J. Zhang, G. Hong, and J. Ni. 2010. One-pot reaction to synthesize PEG-coated hollow magnetite nanostructures with excellent magnetic properties. J. Nanosci. Nanotechnol. 10: 6400-6406.
29. Liu, D. F., W. Wu, J. J. Ling, S. Wen, N. Gu, and X. Z. Zhang. 2011. Effective PEGylation of iron oxide nanoparticles for high performance in vivo cancer imaging. Adv. Funct. Mater. 21: 1498-1504.
30. Denny, J. B., and G. Blobel. 1984. 125I-labeled crosslinking reagent that is hydrophilic, photoactivatable, and cleavable through an azo linkage. Proc. Natl. Acad. Sci. USA. 81: 5286-5290. (Pubitemid 14048732)
31. Trivedi, R. A., C. Mallawarachi, J. M. U-King-Im, M. J. Graves, J. Horsley, M. J. Goddard, A. Brown, L. Wang, P. J. Kirkpatrick, J. Brown, and J. H. Gillard. 2006. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler. Thromb. Vasc. Biol. 26: 1601-1606. (Pubitemid 44288989)
32. Shen, T., R. Weissleder, M. Papisov, A. Bogdanov, Jr., and T. J. Brady. 1993. Monocrystalline iron oxide nanocompounds (MION): physicochemical properties. Magn. Reson. Med. 29: 599-604. (Pubitemid 23138048)
33. Wunderbaldinger, P., L. Josephson, and R. Weissleder. 2002. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug. Chem. 13: 264-268. (Pubitemid 34267937)
34. Radermacher, K. A., N. Beghein, S. Boutry, S. Laurent, L. Vander Elst, R. N. Muller, B. F. Jordan, and B. Gallez. 2009. In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: a multimodal approach using MR imaging and EPR spectroscopy. Invest. Radiol. 44: 398-404.
35. Briley-Saebo, K. C., W. J. Mulder, V. Mani, F. Hyafil, V. Amirbekian, J. G. Aguinaldo, E. A. Fisher, and Z. A. Fayad. 2007. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J. Magn. Reson. Imaging. 26: 460-479. (Pubitemid 350194567)
36. Tsimikas, S., B. P. Shortal, J. L. Witztum, and W. Palinski. 2000. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression. Arterioscler. Thromb. Vasc. Biol. 20: 689-697. (Pubitemid 30151682)
37. Torzewski, M., P. X. Shaw, K. R. Han, B. Shortal, K. J. Lackner, J. L. Witztum, W. Palinski, and S. Tsimikas. 2004. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization. Arterioscler. Thromb. Vasc. Biol. 24: 2307-2312. (Pubitemid 39658034)
38. Tsimikas, S. 2002. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am. J. Cardiol. 90: 22L-27L. (Pubitemid 35379901)
39. Tang, T. Y., S. P. Howarth, S. R. Miller, M. J. Graves, J. M. U-King-Im, Z. Y. Li, S. R. Walsh, A. J. Patterson, P. J. Kirkpatrick, E. A. Warburton, K. Varty, M. E. Gaunt, and J. H. Gillard. 2008. Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis. Stroke. 39: 2144-2147.
40. Falk, E., S. M. Schwartz, Z. S. Galis, and M. E. Rosenfeld. 2007. Putative murine models of plaque rupture. Arterioscler. Thromb. Vasc. Biol. 27: 969-972. (Pubitemid 46606733)
41. von der Thusen, J. H., B. J. van Vlijmen, R. C. Hoeben, M. M. Kockx, L. M. Havekes, T. J. van Berkel, and E. A. Biessen. 2002. Induction of atherosclerotic plaque rupture in apolipoprotein E-/- mice after adenovirus-mediated transfer of p53. Circulation. 105: 2064-2070.
42. Ni, M., Y. Wang, M. Zhang, P. F. Zhang, S. F. Ding, C. X. Liu, X. L. Liu, Y. X. Zhao, and Y. Zhang. 2009. Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice. Am. J. Physiol. Heart Circ. Physiol. 296: H1598-H1606.
43. Johnson, J., K. Carson, H. Williams, S. Karanam, A. Newby, G. Angelini, S. George, and C. Jackson. 2005. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation. 111: 1422-1430. (Pubitemid 40396809)